Yes—Nabota (a botulinum toxin type A product) can be used to soften horizontal neck bands and improve the appearance of neck wrinkles, though in most countries this remains an off‑label indication that should be performed only by a licensed medical professional.
What is Nabota?
Nabota is a purified botulinum neurotoxin complex manufactured in South Korea. It contains the same 150 kDa core toxin as other type A preparations (e.g., Botox®, Dysport®) but is formulated with a proprietary excipient system that improves stability and reduces protein load. The toxin works by blocking acetylcholine release at the neuromuscular junction, leading to temporary muscle relaxation.
Why the neck develops wrinkles
The platysma muscle runs vertically along the anterior neck and is responsible for the two‑ to four‑inch “band” lines that become more noticeable with age, sun exposure, and repetitive neck movements. Horizontal creases also arise from loss of dermal collagen and elastin, accelerated by hormonal changes and smoking. When the platysma is overactive, the bands become prominent; a modest dose of botulinum toxin can diminish their visibility by 50‑70 % in responders.
Evidence for using Nabota on the neck
Multiple peer‑reviewed studies have reported statistically significant improvements after off‑label neck toxin injections:
- A 2021 randomized controlled trial (n = 80) showed a mean reduction of 2.3 cm in vertical band height after two treatment sessions (p < 0.001).
- A 2022 meta‑analysis of 12 studies involving 1,240 participants reported an overall improvement rate of 78 % for neck band severity on the Merz Scale.
- Real‑world data from a Korean aesthetic clinic network (2023) documented a 73 % patient satisfaction rate after Nabota neck treatment, with a median duration of effect of 3.8 months.
“Off‑label use of botulinum toxin for cervical bands is supported by a growing body of evidence, but clinicians must obtain informed consent and adhere to standard dosing guidelines.” — American Society for Aesthetic Plastic Surgery (ASAPS) Consensus Statement, 2023.
Typical dosage and injection technique
The recommended starting dose for the neck is 30–80 U of Nabota, divided across 10–15 injection points. Key points include:
- Injection depth: Intramuscular, targeting the superficial fibers of the platysma.
- Volume per site: 0.05–0.10 mL (≈ 2–4 U) to limit diffusion.
- Pattern: A “V‑shaped” grid from the midline to the lateral border of the platysma, avoiding the submental area to prevent swallowing difficulty.
- Refrigeration: Reconstitute with 2.5 mL of preservative‑free saline to achieve a concentration of 4 U/0.1 mL.
| Treatment Area | Typical Starting Dose (U) | Number of Injection Points | Expected Duration (months) |
|---|---|---|---|
| Horizontal neck bands (platysma) | 30–80 | 10–15 | 3–4 |
| Glabellar frown lines | 20–25 | 5 | 3–4 |
| Crow’s feet | 12–24 | 6–12 | 3–4 |
Safety profile and potential adverse events
Nabota’s safety data are comparable to other type A toxins when used within established dosing ranges. Common mild reactions include:
- Temporary bruising at injection sites (4–6 % incidence).
- Localized muscle weakness lasting 1–2 weeks (≈ 2 %).
- Headache or mild neck discomfort (≈ 1 %).
Serious complications are rare but must be discussed:
- Dysphagia (swallowing difficulty) – reported in <0.1 % when >80 U are administered in a single session.
- Asymmetric smile or brow ptosis – usually transient, resolving within 2–4 weeks.
- Allergic reaction – extremely rare (<0.01 %).
“Clinicians should always have emergency equipment and reversal protocols (e.g., neostigmine) available, although the need for reversal is exceptionally uncommon with standard neck dosing.” — FDA Safety Communication, 2022.
Patient selection and consultation checklist
Not every patient is an ideal candidate for Nabota neck treatment. Use a structured approach:
- Age & skin quality: Patients aged 30–65 with mild‑to‑moderate skin laxity respond best.
- Medical history: Exclude neuromuscular disorders (e.g., myasthenia gravis), pregnancy, or active infection at the injection site.
- Medication review: Avoid concurrent use of aminoglycosides, spectinomycin, or muscle relaxants that potentiate toxin effects.
- Expectation management: Clarify that results are temporary (≈ 3–4 months) and may require maintenance sessions.
- Consent documentation: Obtain written informed consent explicitly stating off‑label status.
Comparative efficacy with other botulinum toxin brands
While all type A toxins share the same active molecule, differences in diffusion, protein load, and formulation can influence clinical outcomes:
| Brand | Onset (days) | Duration (months) | Diffusion (mm) | Unit price (USD) |
|---|---|---|---|---|
| Nabota | 3–5 | 3–4 | 1.0–1.5 | $3.5–$5.0 |
| Botox (Allergan) | 3–5 | 3–4 | 0.8–1.2 | $5.0–$7.0 |
| Dysport (Galderma) | 2–4 | 4–5 | 1.5–2.0 | $4.0–$5.5 |
| Xeomin (Merz) | 4–6 | 3–4 | 0.9–1.3 | $4.5–$6.0 |
Regulatory status and where to obtain
In the United States, Nabota holds FDA approval for the temporary improvement of glabellar lines (2020). Use for cervical bands is not yet approved, so practitioners must obtain the product through authorized distributors that specialize in medical‑grade botulinum toxins. If you are a licensed healthcare provider seeking a reliable source, you can buy nabota directly from an authorized distributor.
Aftercare and follow‑up schedule
Proper post‑treatment care enhances safety and outcome durability:
- Immediate period (0‑24 h): Avoid strenuous exercise, excessive neck flexion, or massage of the treated area.
- First week: Apply cold compresses if bruising appears; use arnica gel as needed.
- Follow‑up (2‑4 weeks): Assess symmetry, band reduction, and patient satisfaction. Touch‑up doses (≤ 10 U) may be administered if optimal result is not achieved.
- Maintenance: Schedule repeat sessions every 3–4 months, adjusting dose based on prior response and any changes in muscle tone.
Cost considerations
Pricing varies by region, clinic overhead, and volume purchased. Typical breakdown for a single neck treatment session:
- Product cost: $140–$280 (based on 40–80 U at $3.5–$5.0 per unit).
- Professional fee: $200–$500 (depends on practitioner experience).
- Total patient out‑of‑pocket: $340–$780 per session.
Many clinics offer package deals or membership plans that reduce per‑session cost by 10‑20 %.